Margaret K. Vernon
Margaret Vernon, Ph.D., serves as senior vice president and general manager for the Evidera Advisory Business Unit within the PPD clinical research business of Thermo Fisher Scientific. In this role, she has global executive leadership and P&L responsibilities for Evidera’s combined consulting practices (data and analytics, evidence synthesis, modeling and communication, development and value/access consulting, as well as patient-centered research, medical writing and health care communications). She also supports the overall patient-centricity strategy for the PPD business. She is a subject matter expert regarding patient-reported outcome (PRO) instrument development and validation programs with a special interest in measurement in rare diseases. She has expertise in regulatory strategy and PRO clinical trial implementation and analysis, as well as significant experience and formal training in both qualitative and quantitative methods.
Dr. Vernon joined Evidera in 2012 as a senior research scientist. In 2016, she was named vice president and general manager of patient-centered research, followed by global head of patient-centered research and medical writing in 2019. She was named senior vice president of patient affairs in 2020 and to her current position in 2022. Prior to Evidera, she was a research scientist for United BioSource LLC. She began her career as a research psychologist with the U.S. Bureau of Labor Statistics.
Dr. Vernon earned a Bachelor of Science in psychology from the University of Illinois at Urbana-Champaign and a Ph.D. in psychology with a concentration in research methods and statistics from Pennsylvania State University.